Tasha Armour, Author at ROC Inc.

Michael is cutely aware of the challenges that cancer presents. Riding 900km to raise funds for Rare Ovarian Cancer.

Ride 4 Research Rider Profile Michael Dalton I’m 66 years old from Emu Park in Central Queensland. I am married to Sandy and have two sons Nicholas and Liam. I currently work in the water and sewage section for Livingstone Shire Council and prior to that spent many years in the minerals industry. My sporting career commenced with swimming where I won state and national masters swimming titles in butterfly culminating in 4th placing and 5th placing in the 200m & 100m butterfly events respectively at 1996 World Master Swimming Championships in Sheffield England. From there I progressed to running […]

I am cycling 900km for my Daughter who was diagnosed with a Rare Ovarian Cancer at 19 years old

Rider Profile: Stephen Mitchell My daughter Katelyn was diagnosed in September 2020 with Juvenile Granulosa Cell Tumour (JGCT), a very rare form of ovarian cancer. Katelyn has had 2 operations, 1 to remove a Tumor and the 2nd to remove an ovary. At the time of her diagnoses the lack of information about this form of cancer lead Katelyn (also leaning on Lynnette and I) to decided that her treatment would be ‘watch n wait’. Chemotherapy was an option but was ineffective as the cancer can still reoccur. As of September 2021 Katelyn is well and all scans have been […]

Honoured to help a mate to make Ride 4 Research happen

ROC Inc Ride 4 Research 2022 – Rider Profile Peter Smith Peter Reaburn and I first met in 1977 on the beach at Coolangatta, while competing in the Queensland Surf Life Saving Titles. We discovered that we were studying Human Movement Studies together at University of Queensland and have been friends ever since. We played rugby and touch football together, surfed together, and went to each other’s weddings. After Uni, I became an Air Traffic Controller, working in Mt. Isa, Sydney, Newcastle, Archerfield, and Brisbane. I retired in 2014. As an ATC, I still was involved in sport and exercise. […]

11-month-old baby Neve’s ovarian tumour was bigger than a softball.

11-month-old baby Neve’s ovarian tumour was bigger than a softball. Imagine being diagnosed with ovarian cancer as a baby. Unfortunately, this was the confronting reality Neve and her parents Jo and Zoe found themselves in on August 1, 2014. Aged just 11 months old, Neve was diagnosed with Juvenile Granulosa Cell Tumour (jGCT) – a recurrent, incurable ovarian cancer that has no effective treatments available post-surgery. Most people associate ovarian cancer as a disease affecting adult women. Few people know that ovarian cancer can be diagnosed at any age and affects females of all ages. So little is known about […]

Fours years ago today

Four years ago today marked the start of Rare Ovarian Cancer Incorporated (ROC Inc) a journey to create a greater public awareness and research for Rare Ovarian Cancer. With no screening test for ovarian cancer, the symptoms are often vague and easy to dismiss. Our goal is to create a greater public awareness for ovarian cancer and its symptoms. In 2019 together with our research partners at the Hudson Institute of Medical Research we initiated the world’s first, and largest research for Juvenile Granulosa Cell Tumour (jGCT) a rare ovarian cancer. In 2020, with the support of ROC Inc, Hudson […]

Raise More Awareness for Ovarian Cancer With Free Downloadable Tools

February is ovarian cancer awareness month, it is an important time at Rare Ovarian Cancer Inc. (ROC Inc), we are passionate about bringing more attention to awareness and to highlight why funded research is so crucial. Ovarian cancer affects females of all ages from babies to post-menopausal women. Have you or someone you care about been impacted by ovarian cancer? Sharing your experience and knowledge with others can have a big impact. You can play an important part in raising awareness in your community about ovarian cancer to help we have created free printable resources posters, bunting and awareness ribbons […]